NCT05262569 is a clinical trial of ileus in Ileus, sponsored by Peking University People's Hospital.

Who is sponsoring NCT05262569?

NCT05262569 is sponsored by Peking University People's Hospital.

What drugs are being tested in NCT05262569?

Interventions in NCT05262569: ileus.

What condition does NCT05262569 study?

NCT05262569 studies Ileus, Opioid Use.

Is NCT05262569 still recruiting?

NCT05262569 is currently completed. Last updated 9 August 2022.

Last reviewed 2022-08-09 · How we verify

NCT05262569

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postoperative Opioid Use and Ileus Occurrence---A Case Control Study

Completed Last updated 9 August 2022

What this trial tests

trial testing ileus in Ileus in 596 participants. Completed in 30 June 2022.

Timeline

1 April 2022

Primary endpoint
31 May 2022

30 June 2022

Quick facts

Lead sponsor	Peking University People's Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	596
Start date	1 April 2022
Primary completion	31 May 2022
Estimated completion	30 June 2022
Sites	1 location across China

Drugs / interventions tested

ileus

Conditions studied

Ileus — all drugs for Ileus →
Opioid Use — all drugs for Opioid Use →

Sponsor

Peking University People's Hospital

Who can join

18 and older, any sex, with Ileus or Opioid Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative ileus (POI) is a significant complication after colorectal surgery, with reported incidence ranging from 10\~30%, leading to increased morbidity, hospital length of stay, and thus medical cost. To determine the risk factors for POI is one of the key elements for Enhanced Recovery after Surgery protocol. Increased perioperative opioid usage has been proposed as an independent risk factor for postoperative ileus, as perioperative opioid minimization has proposed to be an effective measure to decrease the incidence of POI. Although opioids are widely used to attenuate stress during surgery, and represent the cornerstone of pain treatment, anesthesiologists are strive to minimize opioid use to decrease opioid-related GI side effects. In this study, the investigators aim to find out the general occurrence of POI in the laparoscopic colorectal surgery and the effects of the postoperative opioid usage on this outcome. The strategies of opioid minimization was also investigated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Total postoperative opioid dose is an independent risk factor for prolonged postoperative ileus after laparoscopic colorectal surgery: a case-control study.
Ju H, Shen K, Li J, Feng Y. · · 2024 · cited 5× · PMID 37096402 · DOI 10.4097/kja.22792

Verify or expand the search:

Other recruiting trials for Ileus

Currently open trials in the same condition.

NCT07432542 — Pelvic Floor Peritoneal Closure to Prevent Postoperative Ileus in Mid-Low Rectal Cancer Surgery · NA · active not recruiting
NCT06815822 — Prevention of Postoperative Hernias in Emergency Surgery · recruiting

Other Peking University People's Hospital trials

Trials by the same sponsor.

NCT07535645 — Baricitinib for Post-HSCT Persistent Thrombocytopenia · Phase 1, PHASE2 · not yet recruiting
NCT07516002 — Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency · not yet recruiting
NCT07294339 — A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positiv · NA · not yet recruiting
NCT07500441 — Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML · recruiting
NCT07487883 — Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05262569 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University People's Hospital
Last refreshed: 9 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05262569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing